September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Comparative Ocular Effects of Topical Epinephrine Versus Phenylephrine in Ptotic and Non-ptotic Subjects
Author Affiliations & Notes
  • Philip Ngai
    Gavin Herbert Eye Institute, University of California, Irvine, Irvine, California, United States
  • Jeremiah Tao
    Gavin Herbert Eye Institute, University of California, Irvine, Irvine, California, United States
  • Footnotes
    Commercial Relationships   Philip Ngai, None; Jeremiah Tao, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 677. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Philip Ngai, Jeremiah Tao; Comparative Ocular Effects of Topical Epinephrine Versus Phenylephrine in Ptotic and Non-ptotic Subjects. Invest. Ophthalmol. Vis. Sci. 2016;57(12):677.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Injected 1% lidocaine with epinephrine 1:100,000 (LE100), commonly used in blepharoptosis surgery, may elevate the upper eyelid through sympathetic effects on Müller’s muscle (Trans Am Ophthalmol Soc. 1996;94:165-73) and can also induce pupil dilatation. Such stimulation of sympathetic pathways may affect intraoperative assessment during ptosis surgery. Exposure of the ocular surface to LE100 can occur during ptosis repair, though the effects have not been described. Herein we compare the effect of topical LE100 and phenylephrine on upper eyelid position and pupil size.

Methods : Upper eyelid margin reflex distance (MRD-1) and pupil diameter were measured at baseline and 5 minutes after application of topical LE100 in one eye of 14 non-ptotic and 10 ptotic patients. Measurements were obtained by digital photography with each subject’s head and eyes in primary position. After >48 hours each eye was exposed to topical phenylephrine 2.5% and the same measurements were obtained.

Results : Topical LE100 did not produce an increase in mean MRD-1 (p>0.05). Conversely, 19/24 eyes (13 non-ptotic, 6 ptotic) exhibited a significant increase (p<0.01) in MRD-1 (mean 0.59 mm) after application of phenylephrine. Change in MRD-1 was significantly greater (p<0.01) after exposure to phenylephrine than to LE100. 5/24 eyes (1 non-ptotic, 4 ptotic) did not exhibit an increase in MRD-1 in response to phenylephrine; these eyelids also did not elevate in response to LE100. Average pupil size increased 0.24 mm (p=0.013) after exposure to phenylephrine, and 0.27 mm (p<0.01) after instillation of LE100. The effect on pupil diameter was statistically similar between the two solutions (p>0.05).

Conclusions : Topical LE100 and topical phenylephrine had similar effects on pupil size, but not on MRD-1. The measurable response of the iris dilator muscle was not coupled with a statistically significant response of Müller’s muscle. These data may have implications on intraoperative measurements recorded during ptosis surgery. Importantly, a surgeon should not presume there is elevation of the upper eyelid when pupil dilatation is noted after eye exposure to LE100.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×